Global Medical Biological Protein Glue Market Strategic Research Report

Scope of the Report

The global Medical Biological Protein Glue market size is predicted to grow from US$ 501 million in 2025 to US$ 743 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.

In 2025, the global production of medical biological protein glue was 3.3 million units, with an average price of US$147.5 per unit, with a gross profit margin typically between 45% and 65%.

Medical bio-protein glue is a special functional adhesive used in medicine. Its main components typically include functions such as hemostasis, promoting tissue healing, sealing wounds, and preventing adhesions. It is widely used in surgical procedures and wound care, and its mechanism of action is to assist in tissue repair by forming a gel-like substance.

Medical bio-protein glues consist of upstream components such as plasma proteins, fibrinogen, thrombin, lyophilized human or animal-derived protein components, recombinant protein materials, medical buffer solutions, stabilizers, and aseptic filling and lyophilization packaging systems. These raw materials determine its gelation speed, tensile strength, wet adhesion properties, and tissue compatibility. Downstream applications are mainly concentrated in surgical hemostasis, neurosurgical dural repair, thoracic pulmonary leak sealing, cardiovascular effusion control, closure of cut surfaces of hepatobiliary and pancreatic parenchymal organs, and plastic and reconstructive adhesive grafting and fixation. Among these, parenchymal organ resection, complex cardiothoracic surgeries, and neurosurgical dural repair are the fastest-growing segments. Bio-protein adhesives can rapidly solidify in a moist environment during surgery, replacing some sutures and patches, significantly reducing intraoperative bleeding and postoperative leakage rates, and shortening surgical time. Therefore, their penetration rate is significantly improved in high-risk, minimally invasive, and difficult-to-suture tissue scenarios.

Global development trends focus on faster solidification, higher adhesion strength, lower immune response, controllable degradation, and the use of smaller quantities but with stronger effects through high-concentration two-component formulations. Driving factors include the increased difficulty in suturing due to the rising proportion of minimally invasive surgeries, the increased reliance on rapid hemostatic materials due to the rise in high-risk surgeries caused by an aging population, hospitals' higher requirements for intraoperative time and complication control, surgeons' increased preference for predictable hemostatic effects, and the standardization of regulations on high-grade biomaterials driving the penetration of high-quality products. Obstacles mainly stem from the high cost of upstream raw materials such as plasma due to supply constraints, strict regulatory requirements and long certification cycles for human-derived protein products in different countries, ethical and immunological risks associated with animal-derived materials in some markets, insufficient adhesion stability of some products in high-flow-rate blood vessels or high-tension tissues, and hospitals' budget sensitivity to high-priced bioadhesives.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Biological Protein Glue market?

What factors are driving Medical Biological Protein Glue market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Biological Protein Glue market opportunities vary by end market size?

How does Medical Biological Protein Glue break out by Type, by Application?

This report presents a comprehensive overview of the global Medical Biological Protein Glue market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Animal Source
• Human Source
• Recombinant Human Source
• Compound Source

Segment by Function

• Hemostatic Type
• Tissue Adhesive Type
• Wound Repair Type
• Sealing Type

Segment by Degradation Cycle

• 1-2 Weeks
• 3-6 Weeks
• 6-12 Months
• 1-6 Months

Segment by Form

• Gel
• Spray
• Injection
• Sponge/Membrane

Segment by Application

• Neurosurgery
• Cardiovascular Surgery
• Orthopedics
• Dermatology
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Biological Protein Glue market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Neurosurgery, Cardiovascular Surgery, Orthopedics evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact